Alexeeva, E.I.; Dvoryakovskaya, T.M.; Nikishina, I.P.; Zholobova, E.S.; Matkava, V.G.; Krekhova, E.A.; Raupov, R.K.; Bukhanova, D.V.; Egorova, A.N.; Grishin, S.A.;
et al. Open-Label Phase II Study of Olokizumab in Adolescent Patients with Polyarticular Juvenile Idiopathic Arthritis: Results of the 24-Week Treatment Period. Pharmaceuticals 2026, 19, 79.
https://doi.org/10.3390/ph19010079
AMA Style
Alexeeva EI, Dvoryakovskaya TM, Nikishina IP, Zholobova ES, Matkava VG, Krekhova EA, Raupov RK, Bukhanova DV, Egorova AN, Grishin SA,
et al. Open-Label Phase II Study of Olokizumab in Adolescent Patients with Polyarticular Juvenile Idiopathic Arthritis: Results of the 24-Week Treatment Period. Pharmaceuticals. 2026; 19(1):79.
https://doi.org/10.3390/ph19010079
Chicago/Turabian Style
Alexeeva, Ekaterina I., Tatiana M. Dvoryakovskaya, Irina P. Nikishina, Elena S. Zholobova, Valeriya G. Matkava, Elizaveta A. Krekhova, Rinat K. Raupov, Daria V. Bukhanova, Alina N. Egorova, Sergey A. Grishin,
and et al. 2026. "Open-Label Phase II Study of Olokizumab in Adolescent Patients with Polyarticular Juvenile Idiopathic Arthritis: Results of the 24-Week Treatment Period" Pharmaceuticals 19, no. 1: 79.
https://doi.org/10.3390/ph19010079
APA Style
Alexeeva, E. I., Dvoryakovskaya, T. M., Nikishina, I. P., Zholobova, E. S., Matkava, V. G., Krekhova, E. A., Raupov, R. K., Bukhanova, D. V., Egorova, A. N., Grishin, S. A., Samsonov, M. Y., & Kostik, M. M.
(2026). Open-Label Phase II Study of Olokizumab in Adolescent Patients with Polyarticular Juvenile Idiopathic Arthritis: Results of the 24-Week Treatment Period. Pharmaceuticals, 19(1), 79.
https://doi.org/10.3390/ph19010079
